Fig. 1From: Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptanCumulative hazard of recurrence over the 24 h during treatment with frovatriptan (continuous line) or rizatriptan (dashed line) in the 93 women with menstrually related migraine included in this analysisBack to article page